Genetic Epidemiology of Adult Onset Glioma

This study has been completed.
Sponsor:
Collaborator:
DR. Kathleen Egan
Information provided by:
Kentuckiana Cancer Institute
ClinicalTrials.gov Identifier:
NCT00283569
First received: January 26, 2006
Last updated: January 18, 2010
Last verified: January 2010
  Purpose

To establish a clinic based case control study for examination of potential risk factors for primary adult brain tumors.


Condition Intervention
Adult-Onset Glioma
Other: Mouth Swab, Toe Nail Clippings, Questionnaires

Study Type: Observational
Study Design: Observational Model: Case Control
Time Perspective: Prospective
Official Title: Genetic Epidemiology of Adult-Onset Glioma

Resource links provided by NLM:


Further study details as provided by Kentuckiana Cancer Institute:

Biospecimen Retention:   Samples With DNA

Saliva, Toe Nail Clippings


Estimated Enrollment: 100
Study Start Date: May 2004
Study Completion Date: January 2010
Primary Completion Date: January 2010 (Final data collection date for primary outcome measure)
Intervention Details:
    Other: Mouth Swab, Toe Nail Clippings, Questionnaires
    The objective of this study is to establish a clinic based case control study for examination of potential risk factors for primary adult brain tumors.
Detailed Description:

Genetic epidemiology of adult glioma to establish potential risk factors for primary adult brain tumors.

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Sampling Method:   Non-Probability Sample
Study Population

Patients with Glioma and a Control

Criteria

Inclusion Criteria:

  • primary glioma of any stage
  • diagnosed within 4 months
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00283569

Locations
United States, Kentucky
Kentuckiana Cancer Institute
Louisville, Kentucky, United States, 40202
Sponsors and Collaborators
Kentuckiana Cancer Institute
DR. Kathleen Egan
Investigators
Principal Investigator: Renato V. LaRocca, MD Director
  More Information

No publications provided

Responsible Party: Renato V. LaRocca, MD, Kentuckiana Cancer Institute
ClinicalTrials.gov Identifier: NCT00283569     History of Changes
Other Study ID Numbers: mrbt1-03-132, MRBTC2003-01
Study First Received: January 26, 2006
Last Updated: January 18, 2010
Health Authority: United States: Institutional Review Board

Keywords provided by Kentuckiana Cancer Institute:
Glioma

Additional relevant MeSH terms:
Glioma
Neoplasms, Neuroepithelial
Neuroectodermal Tumors
Neoplasms, Germ Cell and Embryonal
Neoplasms by Histologic Type
Neoplasms
Neoplasms, Glandular and Epithelial
Neoplasms, Nerve Tissue

ClinicalTrials.gov processed this record on April 22, 2014